Tufts Medical Center, Boston, MA, USA.
Monmouth Medical Center, Long Branch, NJ, USA.
Hand (N Y). 2023 Oct;18(7):1102-1110. doi: 10.1177/15589447221081565. Epub 2022 Mar 21.
Major League Baseball (MLB) players are at risk for metacarpal fractures; however, little is known regarding the impact of these injuries on future performance. The purpose of this study was to determine whether MLB players who sustain metacarpal fractures demonstrate decreased performance on return to competition in comparison to the performance of control-matched peers.
Data for MLB position players with metacarpal fractures incurred over 17 seasons were obtained from injury reports, press releases, and player profiles. Age, position, career experience, body mass index (BMI), injury mechanism, handedness, and treatment were recorded. Individual season statistics for the 2 seasons immediately before injury and the 2 seasons after injury were obtained. Controls matched by player position, age, BMI, career experience, and performance statistics were identified. A performance comparison of the cohorts was performed.
Overall, 24 players met inclusion criteria. Eleven players with metacarpal fractures were treated with surgery (46%) and 13 (54%) were treated nonoperatively. Players treated nonoperatively missed significantly fewer games following injury compared with those treated operatively (35.5 vs 52.6 games, = .04). There was no significant difference in postinjury performance when compared with preinjury performance among the fracture cohorts. Players with metacarpal fractures treated nonoperatively had a significant decline in their Wins Above Replacement (WAR) 2 seasons postinjury (1.37 point decline) in comparison to matched controls (0.84 point increase) ( = .02). There was no significant difference in WAR 1 or 2 seasons postinjury for players with metacarpal fractures treated operatively in comparison to the control cohort.
Major League Baseball players sustaining metacarpal fractures can expect to return to their preinjury performance levels following both nonoperative and operative treatment. However, players treated nonoperatively may witness a decline in their performance compared with peers over the long term. Orthopedic surgeons treating professional athletes with metacarpal fractures should consider these outcomes when counseling their patients and making treatment recommendations.
美国职业棒球大联盟(MLB)球员存在掌骨骨折的风险;然而,对于这些伤病对未来表现的影响知之甚少。本研究的目的是确定 MLB 中发生掌骨骨折的球员与匹配的对照组相比,在重返赛场时的表现是否降低。
从伤病报告、新闻稿和球员资料中获得了 17 个赛季中发生掌骨骨折的 MLB 位置球员的数据。记录了年龄、位置、职业生涯经验、体重指数(BMI)、损伤机制、惯用手和治疗方法。获得了受伤前的 2 个赛季和受伤后的 2 个赛季的个人赛季统计数据。通过球员位置、年龄、BMI、职业生涯经验和表现统计数据匹配对照组。对两个队列进行了表现比较。
共有 24 名球员符合纳入标准。11 名掌骨骨折的球员接受了手术治疗(46%),13 名(54%)接受了非手术治疗。与接受手术治疗的球员相比,接受非手术治疗的球员在受伤后错过的比赛明显更少(35.5 比 52.6 场, =.04)。在骨折队列中,与受伤前的表现相比,受伤后的表现没有显著差异。与匹配对照组相比,接受非手术治疗的掌骨骨折球员在受伤后 2 个赛季的 WAR(胜利贡献值)明显下降(下降 1.37 分)( =.02)。与对照组相比,接受手术治疗的掌骨骨折球员在受伤后 1 或 2 个赛季的 WAR 没有显著差异。
接受非手术和手术治疗的 MLB 掌骨骨折球员有望恢复到受伤前的表现水平。然而,与同龄人相比,接受非手术治疗的球员可能会在长期内看到自己的表现下降。治疗掌骨骨折的专业运动员的骨科医生在为患者提供咨询和做出治疗建议时,应考虑到这些结果。